Earnings Call · Q2 FY2025·2025-08-14

Q2 25EPS +8.38%·Rev n/aQ1 25EPS +14.29%·Rev n/aQ4 24EPS +97.16%·Rev n/aQ3 24EPS +0.89%·Rev n/a⚠ consensus missing

Cellectar Biosciences, Inc. CLRB

Anne Marie Fields — Managing Director

James V. Caruso — President and CEO

Chad J. Kolean — Chief Financial Officer

Jarrod Longcor — Chief Medical Officer

0.0%1d on move date0.0% vs SPY3d+6.3%5d−0.2%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CLRB calls or request research access.

More CLRB calls Browse calls Request research access